Over the last 7 days, the Pharma industry has remained flat, although notably Eli Lilly gained 3.3%. As for the the longer term, the industry is up 17% over the past 12 months. As for the next few years, earnings are expected to grow by 28% per annum.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 16 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.3x | 137.4x | 5.4x |
Tue, 14 May 2024 | US$1.9t | US$358.2b | US$13.8b | 18x | 134.6x | 5.2x |
Thu, 11 Apr 2024 | US$1.8t | US$355.1b | US$23.9b | 23.4x | 77.3x | 5.2x |
Sat, 09 Mar 2024 | US$1.9t | US$357.3b | US$20.0b | 21.9x | 94x | 5.3x |
Mon, 05 Feb 2024 | US$1.8t | US$353.1b | US$22.0b | 31.7x | 81.4x | 5.1x |
Wed, 03 Jan 2024 | US$1.7t | US$375.2b | US$33.8b | 27.4x | 51x | 4.6x |
Fri, 01 Dec 2023 | US$1.6t | US$375.1b | US$33.9b | 26.6x | 48.2x | 4.4x |
Sun, 29 Oct 2023 | US$1.6t | US$383.5b | US$46.6b | 14.2x | 34.1x | 4.1x |
Tue, 26 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 19.9x | 38.3x | 4.4x |
Thu, 24 Aug 2023 | US$1.8t | US$381.6b | US$44.1b | 19x | 40.2x | 4.6x |
Sat, 22 Jul 2023 | US$1.7t | US$394.3b | US$60.5b | 18.6x | 28.7x | 4.4x |
Mon, 19 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 19x | 29x | 4.4x |
Wed, 17 May 2023 | US$1.7t | US$393.1b | US$60.4b | 19.3x | 28.5x | 4.4x |
Fri, 14 Apr 2023 | US$1.7t | US$401.3b | US$68.5b | 17.7x | 24.5x | 4.2x |
Sun, 12 Mar 2023 | US$1.5t | US$401.1b | US$69.6b | 17.4x | 21.9x | 3.8x |
Tue, 07 Feb 2023 | US$1.7t | US$402.0b | US$69.9b | 18.2x | 23.7x | 4.1x |
Thu, 05 Jan 2023 | US$1.8t | US$403.7b | US$70.7b | 17.1x | 24.8x | 4.3x |
Sat, 03 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 17.2x | 25.3x | 4.4x |
Mon, 31 Oct 2022 | US$1.7t | US$404.8b | US$70.8b | 16.1x | 24.1x | 4.2x |
Wed, 28 Sep 2022 | US$1.5t | US$403.0b | US$71.3b | 12.6x | 21.7x | 3.8x |
Fri, 26 Aug 2022 | US$1.6t | US$402.9b | US$70.1b | 14.7x | 23.2x | 4x |
Sun, 24 Jul 2022 | US$1.7t | US$393.1b | US$63.6b | 22.2x | 26.1x | 4.2x |
Tue, 21 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20.4x | 24.2x | 4x |
Thu, 19 May 2022 | US$1.7t | US$392.5b | US$64.7b | 20x | 25.9x | 4.3x |
Sat, 16 Apr 2022 | US$1.7t | US$373.7b | US$60.9b | 22.7x | 27.8x | 4.5x |
Mon, 14 Mar 2022 | US$1.6t | US$373.8b | US$60.3b | 19.5x | 26.1x | 4.2x |
Wed, 09 Feb 2022 | US$1.6t | US$365.5b | US$53.0b | 21.3x | 29.6x | 4.3x |
Fri, 07 Jan 2022 | US$1.6t | US$361.1b | US$37.8b | 23.5x | 42.6x | 4.5x |
Sun, 05 Dec 2021 | US$1.5t | US$361.1b | US$38.1b | 22.7x | 40.4x | 4.3x |
Tue, 02 Nov 2021 | US$1.6t | US$344.2b | US$31.3b | 20.7x | 50.9x | 4.6x |
Thu, 30 Sep 2021 | US$1.5t | US$337.6b | US$25.8b | 21.7x | 58.1x | 4.4x |
Sat, 28 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 21.2x | 61.1x | 4.7x |
Sun, 04 Jul 2021 | US$1.5t | US$324.4b | US$20.4b | 23.4x | 73.2x | 4.6x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.25% | |
Healthcare | -0.40% | |
Pharma | 0.43% | |
Pharma | 0.43% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$878.45 | 3.3% +US$25.6b | 96.2% | PE128.9x | |
TEVA Teva Pharmaceutical Industries | US$17.16 | 2.0% +US$385.1m | 127.6% | PS1.2x | |
VRNA Verona Pharma | US$15.14 | 24.8% +US$244.1m | -28.7% | PB5.5x | |
PHVS Pharvaris | US$18.76 | 19.7% +US$166.3m | 61.4% | PB2.6x | |
OCUL Ocular Therapeutix | US$5.75 | 16.4% +US$125.5m | 19.5% | PS14.9x |